Filter
1528
Text search:
Pharmaceutical
Assessment
Featured
139
391
Language
Document type
788
300
233
74
71
20
19
12
5
3
2
1
Countries / Regions
65
63
59
53
38
37
36
35
31
29
28
26
24
23
22
21
20
20
18
16
15
14
14
14
12
11
10
10
9
9
9
8
8
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
661
109
76
46
32
24
11
1
Toolboxes
154
134
131
89
69
68
45
38
36
28
28
26
26
22
14
11
9
7
6
5
2
1
1
1
COTS (Cholera Outbreak Training and Shigellosis) Program Health Promotion Worker Pocket Card
recommended
Proper Sanitation is the only method to success
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO
...
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
3rd edition!Large File 17 MB!
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...